Chicago, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia surgical treatment market was valued at US$ 10.5 billion in 2024 and is expected to reach us$ 16.5 billion by 2033, ...
Chicago, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia surgical treatment market was valued at 10.5 billion in 2024 and is expected to reach US$ 16.5 billion by 2033, ...
"The large share of North America can be attributed to the region's highly developed healthcare infrastructure and reimbursement system, the increasing number of advanced treatment procedures like ...
Astute Analytica stands out as a premier provider of comprehensive Benign Prostatic Hyperplasia Surgical Treatment Market research reports specifically tailored for the healthcare sector. Our ...
The global Benign Prostatic Hyperplasia Surgical Treatment Market size was valued at USD 2,042.94 million in 2024 and is expected to grow at a CAGR of 5.3% The aging male population's growing need for ...
Astute Analytica released an extensive market assessment report titled “Global Benign Prostatic Hyperplasia Surgical Treatment Market: Trends, Industry Competition Analysis, Revenue, and Forecast to ...
At University of Utah Health, our urologists have years of experience treating men with enlarged prostate issues — also known as benign prostatic hyperplasia (BPH). When other lines of treatment ...
(MENAFN- GlobeNewsWire - Nasdaq) An expanding elderly demographic is fueling growth, while a clear market shift towards minimally invasive procedures challenges the dominance of traditional surgeries, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results